184 related articles for article (PubMed ID: 15784466)
1. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.
López-Vázquez A; Miña-Blanco A; Martínez-Borra J; Njobvu PD; Suárez-Alvarez B; Blanco-Gelaz MA; González S; Rodrigo L; López-Larrea C
Hum Immunol; 2005 Mar; 66(3):285-9. PubMed ID: 15784466
[TBL] [Abstract][Full Text] [Related]
2. The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome.
López-Larrea C; Njobvu PD; González S; Blanco-Gelaz MA; Martínez-Borra J; López-Vázquez A
Arthritis Rheum; 2005 Jan; 52(1):275-9. PubMed ID: 15641063
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
4. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872
[TBL] [Abstract][Full Text] [Related]
5. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
[TBL] [Abstract][Full Text] [Related]
6. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
[TBL] [Abstract][Full Text] [Related]
7. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
8. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
[TBL] [Abstract][Full Text] [Related]
9. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
[TBL] [Abstract][Full Text] [Related]
10. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
[TBL] [Abstract][Full Text] [Related]
11. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
[TBL] [Abstract][Full Text] [Related]
12. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
15. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
16. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
[TBL] [Abstract][Full Text] [Related]
17. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
18. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.
Boulet S; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
AIDS; 2008 Mar; 22(5):595-9. PubMed ID: 18317000
[TBL] [Abstract][Full Text] [Related]
19. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
[TBL] [Abstract][Full Text] [Related]
20. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.
Lopez-Larrea C; Blanco-Gelaz MA; Torre-Alonso JC; Bruges Armas J; Suarez-Alvarez B; Pruneda L; Couto AR; Gonzalez S; Lopez-Vázquez A; Martinez-Borra J
Arthritis Res Ther; 2006; 8(4):R101. PubMed ID: 16805919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]